Digma System First in Human (FIH) Study
NCT: NCT07331857 · RECRUITING
Brief Summary
Prospective, open-label, single-arm, early feasibility study (EFS) in 2 Patient cohorts: Cohort A - Dose finding / Dose response study in patients with various etiologies undergoing Esophagectomy and Cohort B - Patients with Barrett's Esophagus (BE) with Low-Grade Dysplasia (LDG) or High-Grade Dysplasia (HGD) without a visible (excisable) lesion. This is a pilot study which plan to enroll up to 5 eligible patients in the First Cohort (A) and up to 15 patients in the Second Cohort (B) of the study.
Frequently Asked Questions
What is Digma System First in Human (FIH) Study?
Digma System First in Human (FIH) Study is a clinical trial registered under NCT07331857. Current status: RECRUITING.
What is the status of NCT07331857?
The current status of NCT07331857 (Digma System First in Human (FIH) Study) is: RECRUITING.
When did Digma System First in Human (FIH) Study start?
Digma System First in Human (FIH) Study started on 2026-05-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.